Abcam
Pionyr Immunotherapeutics, Abcam Exploring Potential CDx for Anti-TREM2 Therapy
The drugmaker will assess Abcam's anti-TREM2 antibody as a diagnostic tool to identify patients with TREM2-expressing macrophages in tumor samples.
The drugmaker will assess Abcam's anti-TREM2 antibody as a diagnostic tool to identify patients with TREM2-expressing macrophages in tumor samples.